SlideShare a Scribd company logo
1 of 4
Aarkstore.com announces- 10% Discount on This Report till 31st October
2012.

Contract Manufacturing Organizations to 2018 - Cost
Advantages and Improving Quality Standards Build
Confidence and Encourage Foreign Investment in Asian
CMOs




You can also request for sample page of above mention reports on
sample@aarkstore.com




Summary

GBI Research, the leading business intelligence provider, has released its latest
report, “Contract Manufacturing Organizations to 2018 - Cost Advantages and
Improving Quality Standards Build Confidence and Encourage Foreign Investment
in Asian CMOs”, which provides key data, information and analysis of the Contract
Manufacturing Organization (CMO) industry. The report provides a comprehensive
insight into the size of the CMO market, and includes forecasts, key reasons for
outsourcing, the geographical landscape of CMO’s, profiles of top CMOs, regulatory
frameworks, drivers and restraints and deals analysis.

Scope

- Detailed overview of the CMO industry.
- Annualized market data and forecasts for the CMO market.
- Detailed overview of key reasons behind outsourcing, outsourcing service models
and key drivers and restraints of the market.
Reasons to buy

- Develop market-entry and market expansion strategies by identifying areas for
high growth and opportunities.
- Understand the factors shaping the CMO market.

Table of contents:

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Contract Manufacturing Organizations to 2018 - Introduction 7
2.1 GBI Research Guide 7
3 Contract Manufacturing Organizations to 2018 - Industry Overview 8
3.1 Current Status of Pharmaceutical Industry 8
3.2 Cost Optimization Steps for the Pharmaceutical Companies 8
3.2.1 Reduction in Physical Assets 9
3.2.2 Downsizing Manufacturing 9
3.2.3 Reduction in R&D Spending 10
3.3 What CMOs are and Reasons for Outsourcing to Them 12
3.3.1 Different Types of CMOs and the Range of Services Provided by Them 12
3.3.2 How Does Outsourcing to CMOs Take Place? 14
3.3.3 Key Outsourcing Models 16
3.3.4 Key Benefits of Outsourcing 18
4 Contract Manufacturing Organizations to 2018 - Market Characterization 21
4.1 Market Forecasts 21
5 Contract Manufacturing Organizations to 2018 - Geographical Landscape 23
5.1 Introduction 23
5.2 Established Markets 24



List of Figures

List of Tables are also include.
For more Discounted Reports Plz follow The links:


Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive
Procedures and Reimbursement for New Indications to Increase Uptake

Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving
Quality Standards Build Confidence and Encourage Foreign Investment in Asian
CMOs

Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight
Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication
Remains a Challenge

Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control,
Defects in Design of Device, Software or Other Components are the Major Reasons
for Recall

Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key
Regions for Infrastructure Investments for Capacity Additions



Search More Reports Related to This Category :



Medical Equipment
http://www.aarkstore.com/market-sector-reports/Devices-209.html




For More details Plz do contact :

Aarkstore Enterprise
Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

More Related Content

More from Rose088

Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
Rose088
 

More from Rose088 (20)

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 

Contract manufacturing organizations to 2018 cost

  • 1. Aarkstore.com announces- 10% Discount on This Report till 31st October 2012. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs You can also request for sample page of above mention reports on sample@aarkstore.com Summary GBI Research, the leading business intelligence provider, has released its latest report, “Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs”, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry. The report provides a comprehensive insight into the size of the CMO market, and includes forecasts, key reasons for outsourcing, the geographical landscape of CMO’s, profiles of top CMOs, regulatory frameworks, drivers and restraints and deals analysis. Scope - Detailed overview of the CMO industry. - Annualized market data and forecasts for the CMO market. - Detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
  • 2. Reasons to buy - Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities. - Understand the factors shaping the CMO market. Table of contents: 1 Table of Contents 3 1.1 List of Tables 5 1.2 List of Figures 6 2 Contract Manufacturing Organizations to 2018 - Introduction 7 2.1 GBI Research Guide 7 3 Contract Manufacturing Organizations to 2018 - Industry Overview 8 3.1 Current Status of Pharmaceutical Industry 8 3.2 Cost Optimization Steps for the Pharmaceutical Companies 8 3.2.1 Reduction in Physical Assets 9 3.2.2 Downsizing Manufacturing 9 3.2.3 Reduction in R&D Spending 10 3.3 What CMOs are and Reasons for Outsourcing to Them 12 3.3.1 Different Types of CMOs and the Range of Services Provided by Them 12 3.3.2 How Does Outsourcing to CMOs Take Place? 14 3.3.3 Key Outsourcing Models 16 3.3.4 Key Benefits of Outsourcing 18 4 Contract Manufacturing Organizations to 2018 - Market Characterization 21 4.1 Market Forecasts 21 5 Contract Manufacturing Organizations to 2018 - Geographical Landscape 23 5.1 Introduction 23 5.2 Established Markets 24 List of Figures List of Tables are also include.
  • 3. For more Discounted Reports Plz follow The links: Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key Regions for Infrastructure Investments for Capacity Additions Search More Reports Related to This Category : Medical Equipment http://www.aarkstore.com/market-sector-reports/Devices-209.html For More details Plz do contact : Aarkstore Enterprise